Hanseatic Management Services Inc Lantheus Holdings, Inc. Transaction History

Hanseatic Management Services Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	BUY	$82.41 - $99.65 $4,944 - $5,979	60 New	60 $5,000
Q1 2023 May 12, 2023	BUY	$47.76 - $82.86 $5,492 - $9,528	115 New	115 $6,000
Q3 2022 Nov 08, 2022	SELL	$61.42 - $86.29 $3,685 - $5,177	-60 Reduced 0.7%	8,561 $602,000
Q2 2022 Aug 05, 2022	BUY	$55.54 - $72.65 $472,423 - $617,960	8,506 Added 7396.52%	8,621 $569,000
Q1 2022 Apr 29, 2022	SELL	$24.28 - $56.64 $4,079 - $9,515	-168 Reduced 59.36%	115 $6,000
Q2 2021 Jul 30, 2021	BUY	$19.51 - $27.64 $5,521 - $7,822	283 New	283 $8,000

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.59B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.